121 related articles for article (PubMed ID: 24989813)
1. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
[TBL] [Abstract][Full Text] [Related]
2. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
Pelascini LP; Janssen JM; Gonçalves MA
Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8
Cousin C; Oberkampf M; Felix T; Rosenbaum P; Weil R; Fabrega S; Morante V; Negri D; Cara A; Dadaglio G; Leclerc C
Cell Rep; 2019 Jan; 26(5):1242-1257.e7. PubMed ID: 30699352
[TBL] [Abstract][Full Text] [Related]
6. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
[TBL] [Abstract][Full Text] [Related]
7. Basic research on cerebellar gene therapy using lentiviral vectors.
Hirai H
Cerebellum; 2012 Jun; 11(2):443-5. PubMed ID: 22120847
[TBL] [Abstract][Full Text] [Related]
8. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
Front Immunol; 2018; 9():171. PubMed ID: 29459873
[TBL] [Abstract][Full Text] [Related]
9. A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.
Vijayraghavan S; Kantor B
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286484
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.
Pelascini LP; Maggio I; Liu J; Holkers M; Cathomen T; Gonçalves MA
Hum Gene Ther Methods; 2013 Dec; 24(6):399-411. PubMed ID: 24059449
[TBL] [Abstract][Full Text] [Related]
11. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.
Chick HE; Nowrouzi A; Fronza R; McDonald RA; Kane NM; Alba R; Delles C; Sessa WC; Schmidt M; Thrasher AJ; Baker AH
Hum Gene Ther; 2012 Dec; 23(12):1247-57. PubMed ID: 22931362
[TBL] [Abstract][Full Text] [Related]
12. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice.
Fontana JM; Christos PJ; Michelini Z; Negri D; Cara A; Salvatore M
PLoS One; 2014; 9(5):e97270. PubMed ID: 24824623
[TBL] [Abstract][Full Text] [Related]
14. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
16. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
Takayama K; Torashima T
J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
[TBL] [Abstract][Full Text] [Related]
17. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
18. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
[TBL] [Abstract][Full Text] [Related]
19. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.
Torashima T; Koyama C; Iizuka A; Mitsumura K; Takayama K; Yanagi S; Oue M; Yamaguchi H; Hirai H
EMBO Rep; 2008 Apr; 9(4):393-9. PubMed ID: 18344973
[TBL] [Abstract][Full Text] [Related]
20. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium.
Loewen N; Leske DA; Chen Y; Teo WL; Saenz DT; Peretz M; Holmes JM; Poeschla EM
J Gene Med; 2003 Dec; 5(12):1009-17. PubMed ID: 14661176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
